REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/16/2026
Back to search
Official data from USPTO
GEORGE KING BIO-MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GEORGE KING BIO-MEDICAL
ST13
US500000087161862Class
5
Filing
87161862
Registration
5203590
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
05/17/2026
Trademark type
Word
Nice classes
5
Filing date
09/06/2016
Registration date
05/16/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2022
Last transaction
05/17/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
1996-06-00
First use in commerce
1996-06-00
Drawing code
4
Owner type
03
Owner location
Overland Park, KS, US
Examiner
FLEMING, STEPHANIE
Law office
M80
Current location
TMO LAW OFFICE 117
Holders and representatives
Holders
George King Bio-Medical, Inc.
Representatives
Dianne Smith-Misemer HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical diagnostic reagents
Publications
History of USPTO decisions and trademark events.
21 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/31/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/31/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/31/2022
E815
TEAS SECTION 8 & 15 RECEIVED
06/16/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2017
PUBO
PUBLISHED FOR OPPOSITION
02/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/18/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2017
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
12/19/2016
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
12/19/2016
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
12/19/2016
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
12/19/2016
DOCK
ASSIGNED TO EXAMINER
12/13/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2016
NWAP
NEW APPLICATION ENTERED
09/09/2016
Continuous trademark protection
Get notified about every new filing that threatens GEORGE KING BIO-MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.